ASSOCIATION OF BRITISH NEUROLOGISTS SPRING MEETING, 30 March – 1 April 2005 at Queen’s University, Belfast PROGRAMME Wednesday 30 March 2005
am Committee Meetings
Meeting of Clinical Directors and Lead Clinicians Afternoon Session 1 1400 Introduction and Welcome: Dr Stanley Hawkins Topic: Structure of neurological care Chairman: Dr J Morrow
Sue Barrow, Associate Programme Director
Email triage for new neurological outpatient referrals: what the customers think
The ability of a nurse specialist to diagnose simple headache disorders compared with
Afternoon Session 2 Topic: Movement disorders Chairman: Professor C Kennard 1600
Could analysis of ocular fixation improve the clinical diagnosis of Parkinsonism?
Levodopa acutely improves alertness in Parkinsonism
The Royal College and the Specialities: a special relationship
Neurological conditions and their co-morbidities Satellite Symposium, sponsored by Pfizer Common mechanisms, common modulation: neuropathic pain, epilepsy and their co-Psychiatric and behavioural co-morbidities in epilepsy Co-morbidities in neuropathic pain: a balancing act Chair round up & questions and answers followed by Dinner for Symposium delegates organized by Pfizer Thursday 31 March 2005 0800 Morning Session 1 Topic: Neuromuscular, eye & stroke disorders Chairman: Professor DW Chadwick
0900
Carotid stenting techniques have evolved since CAVATAS, but have they had an
impact on peri-operative morbidity? Does the Sheffield stenting register provide a clue?
The Third International Stroke Trial (IST-3). Thrombolysis for acute ischaemic stroke
Neuromyelitis optica in the United Kingdom
Facial involvement in MuSK antibody positive myasthenia gravis
Treating the untreatable: exercise-induced stem cell activation as a novel treatment
Morning Session 2 Topic: Epilepsy & miscellaneous Chairman: Dr PEM Smith 1100
Management of epilepsy in the community: an irish general practitioner's perspective
Imaging the neocortex in epilepsy with advanced magnetic resonance imaging
Clinical' 1.5 Tesla and 'specialist' 3 Tesla magnetic resonance imaging in presurgical
Can we predict malignant transformation in low-grade gliomas by measuring growth
Usefulness of investigation in a first seizure clinic
No more neurophobia: making neurology teaching accessible to medical students
Outsourcing neurology night-time cover using intercontinental telemedicine
Professor Rory Collins, University of Oxford
Afternoon Session 1 Chairman: Dr V Patterson
1500
Heroes and hooligans: sodium channels and their many roles in neurological disease
Professor Stephen Waxman, Yale University School of Medicine, USA
Afternoon Session 2
Steam Train departs from Botanic Station
Reception and Dinner, Ulster Folk & Transport Museum
Friday 1 April 2005 Morning Session 1 Topic: Multiple sclerosis & imaging Chairman: Dr DE Bateman
Spinal cord atrophy in multiple sclerosis is due to white matter volume loss
A cannabis-based medicine (Savitex) has sustained efficacy in the treatment of
An audit of the use of modafinil in clinical practice for the treatment of fatigue in
Fifty years of epidemiological studies of multiple sclerosis in Northern Ireland
A genomic map of the candidate susceptibility loci of multiple sclerosis in Northern
Trends in survival and cause of death in patients with multiple sclerosis in Northern
Multi-nodal magnetic resonance imaging and spectroscopy in normal pressure
Morning Session 2 Topic: Dementia Chairman: Dr SA Hawkins 1100
Two simple questions in the identification of dementia
Brain biopsy in dementia: a review of 90 consecutive cases from Queen Square
Tonsil biopsy in the investigation of suspected variant Creutzfeldt-Jakob disease:
Department of Microbiology, Queen’s University, Belfast
Afternoon Session Topic: Stroke Chairman: Professor CP Warlow
Thrombolysis for stroke in the UK: room for improvement?
Professor Peter Sandercock , Western General Hospital Edinburgh
Does reliable diagnosis of TIA require a neurologist?
Professor Peter Rothwell, Radcliffe Infirmary, Oxford
POSTER SESSION THURSDAY 31 MARCH 2005 AT 1345 – 1500 hrs Dementia P1
Knight's move thinking? Mild cognitive impairment in a chess player
Sporadic Creutzfeldt-Jakob disease identified only at autopsy: why are cases missed in life?
Creutzfeldt Jakob disease (CJD) associated with human dura mater - experience from UK surveillance
Non convulsive status epilepticus in Creutzfeldt-Jakob disease - a short report
Epilepsy P7
Magnetization transfer spectroscopy in patients with epilepsy
Costs and outcomes of pregabalin versus other new anti-epileptic drugs indicated as add-on therapy in
MR-tractography predicts visual field defects following temporal lobe resection
The prevalence of structural abnormalities in clinically selected patients with chronic headache and seizure
Tolerability of polytherapy with sodium valproate, topiramate and lamotrigine
Inflammation P12
An audit of the use of laboratory diagnostic tests in herpes simplex virus encephalitis
Voltage gated potassium channel antibody associated limbic encephalitis: a case of acute amnesia and
The UK multiple sclerosis database: A tool for MS care and research
Diagnostic yield of brain biopsy in neurology patients at Atkinson Morley Hospital (AMH), 1993-2002
Neuropathological features of multiple sclerosis (MS) can be seen in a humanized mouse model of EAE
A pharmacogenetic screen of 100 interferon regulated genes in relation to (non-) responsiveness to IFN-β
Interlukin-4 and interlukin-4 receptor polymorphisms: influence on clinical course of multiple sclerosis
Polymorphisms in the interferon-gamma gene modify sex-associated risk for multiple sclerosis
Miscellaneous
P20
Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic
Spondyloepiphyseal dysplasia presenting with cervical myelopathy
The outcome of referral of patients with functional neurological symptoms or psychiatric disorders for
psychological therapy from a general clinic - a pilot study
Neuroradiology in a district general hospital
Trigeminal neuralgia as a presenting feature of Lhermitte Duclos disease
Viral vectors for immunisation against potassium channel Kv1.2
The comprehensive neurological examination in 1897 compared with 2002 - from Hutchison's clinical
Fragile-x-associated tremor/ataxia syndrome in a woman unmasked by chemotherapy
Email teleneurology to the developing world: the experience of the Swinfen Charitable Trust
Movement Disorders P29
The role of the acute dopaminergic challenge re-visited
New levodopa/carbidopa/entacapone (Stalevo®) provides better quality of life for Parkinson's disease
Chorea associated with thyroxine replacement therapy
Treatment change in the first 12 months of Parkinson's disease treatment
Differentiating drug-induced parkinsonism from Parkinson's disease with FP-CIT SPECT (DaTSCAN):
Sydenham's chorea with anti-basal ganglia antibodies, new-onset diabetes mellitus and prominent basal
The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy
Neuromuscular P36
Tacrolimus induced chronic inflammatory demyelinating polyneuropathy and ischaemic stroke
Childhood onset demyelinating neuropathy and cataracts: a potentially treatable disorder
A nosological case study of Brown-Vialetto-Van Laere syndrome using neurophysiological and proton
magnetic resonance spectroscopy techniques
Mycophenolate mofetil for dysimmune neuromuscular diseases: experience in a
Muscle sampling in inclusion body myositis
The genetic diagnosis of congenital myasthenic syndromes (CMS)
A sting in the tale - a unique case of wasp-induced autoimmune neuromyotonia
Stroke P44
Acute ischaemic stroke management: numbers not treated
Antiplatelet agents for secondary stroke prevention. Has primary care taken on board the RCP guidance?
Ascending myelopathy following spinal cord injury is probably due to venous infarction
Location-specific volume of early perihaematoma oedema
Use of arch aortography for assessment of carotid stenosis prior to stenting or surgery. The Sheffield
Plasma D-dimer levels in intracranial venous thrombosis
Zappelphilipps, Indigo Kinder, ADHD . oder was? Hyperaktive Kinder sind anstrengend und häufig eine Prüfungi für Eltern, Kindergärtnerinnen, Schulen, Lehrer/innen, Aerzte. An diesen unruhigen und unaufmerksamen Kindern können Eltern, Lehrer und andere Bezugspersonen immer wieder scheitern, indem sie an den Rand ihrer Möglichkeiten geraten, diese Kinder erzieherisch positiv zu beein
BIGORIO 2003 DYSPNOE Consensus on best practice in Palliative Care in Switzerland – expert group Swiss Society for Palliative Care – 1. Wo liegt das Problem? 2.2. Evaluation Bei fortgeschrittenen Krebserkankrungen ist Dyspnoe eine Spezifische Anamnese häufige Erscheinung. Obwohl es Behandlungsmöglich-keiten gibt, wird Dyspnoe von den Patienten wenig er-– Beginn: akut